Author: News Room
DUBAI, United Arab Emirates, Dec. 13, 2024 (GLOBE NEWSWIRE) — Introducing the Banana Republic Ecosystem of Digital Nation. In an era of unprecedented global challenges, a revolutionary force has emerged that is uniting people across borders, cultures, and ideologies. Enter the Banana Republic, a community-driven initiative that redefines governance, fosters inclusivity, and promotes creativity as a catalyst for change. Far from a traditional nation-state, the Banana Republic is a bold experiment in how humour, shared values, and collective action can tackle some of the world’s most pressing issues—all while staying grounded in a vision of fairness, transparency, and sustainability. The…
SHANGHAI, Dec. 13, 2024 (GLOBE NEWSWIRE) — AFK Journey—the multi-award winning sequel to the global smash hit AFK Arena—is being celebrated as the winner of both the Google Play “Best Game of 2024” and the Apple App Store “Best iPhone Game of the Year” awards, leading all other mobile video games released on both platforms in the year 2024. Farlight Games, the global publishing brand of Lilith Games, is proud to reflect on the success of the free-to-play fantasy RPG following its launch on PC and mobile platforms earlier this year. “AFK Journey’s expansive roster of characters and satisfying tactical…
LA, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) — Acclaimed singer-songwriter Darrell Kelley is proud to announce the release of his latest single, “Neither One of Us,” a soul-stirring cover of the 1973 classic. Kelley’s rendition of “Neither One of Us” showcases his exceptional vocal talent and emotional depth, breathing new life into this timeless ballad. His soulful voice effortlessly navigates the song’s intricate melody, hitting every note with precision and passion. Kelley’s vocal range is a testament to his skill and dedication as a singer, earning him comparisons to legendary vocalists. With his unique interpretation, Kelley cements his reputation as…
SAN DIEGO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company’s senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued in connection with the Company’s initial public offering (“IPO”). Kyverna is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTX)…
SAN DIEGO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Marqeta, Inc. (NASDAQ: MQ) securities between August 7, 2024 and November 4, 2024. Marqeta creates digital payment technology for innovation leaders. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Marqeta, Inc. (MQ) Failed to Disclose the Impact of Regulatory Scrutiny on its Business Prospects According to the complaint, during the class period,…
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) — The “GCC Luxury Market by Type, Gender, Distribution Channel and Region 2024-2032” report has been added to ResearchAndMarkets.com’s offering.The GCC luxury market size reached US$ 15.5 billion in 2023. Looking forward, the market is projected to reach US$ 35.2 billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2023-2032. This report provides a deep insight into the GCC luxury market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five…
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) — The “Enzymatic DNA Synthesis Market by Technology, Component, Application – Global Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.The Enzymatic DNA Synthesis Market grew from USD 4.87 billion in 2023 to USD 5.37 billion in 2024. It is expected to continue growing at a CAGR of 10.51%, reaching USD 9.82 billion by 2030. The market is primarily driven by an increasing demand for DNA-based therapeutics and vaccines, advancements in personalized medicine, and growing interest in synthetic biology as a tool for tackling complex biological challenges. Additionally, rising research and development investments to…
MONTREAL, Dec. 13, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company”) is pleased to provide a progress update for its ongoing bulk sample and underground development activities at its 100%-owned Cariboo Gold Project (“Cariboo” or the “Project”) located in central British Columbia (“BC”), Canada. The Company has now successfully completed 100% of the underground development, totalling approximately 1,172 meters, to access the target area of the contemplated bulk sample in the Lowhee Zone of the deposit. Preparations are underway and in their final stages to extract 10,000 metric tonnes of mineralized material.…
TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced a high-profile interview with President Eiji Nagahara in Bloomberg Businessweek published on December 1st. Management feels that the history and reach of Bloomberg Businessweek will help to spread the story of Lead Real Estate. “I am delighted to share our company’s vision with Bloomberg Businessweek’s influential readership among investors throughout the world. It’s rewarding that such a vaunted financial news…
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) — The “Precision Medicine – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.The global market for Precision Medicine was estimated at US$89.9 Billion in 2023 and is projected to reach US$161.1 Billion by 2030, growing at a CAGR of 8.7% from 2023 to 2030.The precision medicine market is experiencing rapid growth, driven by a combination of technological advancements, increased healthcare spending, and a growing emphasis on personalized treatments. One of the primary growth drivers is the declining cost of genomic sequencing, which is making genetic testing more accessible to a larger population.…